Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
about
Multiple roles for nicotine in Parkinson's diseaseNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseaseVocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease.Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease.Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study.Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication.Behavioral phenotyping of mouse models of Parkinson's disease.The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseTreadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis.Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated miceNociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonism.Korean Red Ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model.Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson diseaseThe hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.Tricyclic Antidepressants Amitriptyline and Desipramine Induced Neurotoxicity Associated with Parkinson's Disease.Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's diseaseReduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Quantitative measurement of postural sway in mouse models of human neurodegenerative diseaseImpact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's diseaseDown-regulation of p21-activated serine/threonine kinase 1 is involved in loss of mesencephalic dopamine neurons.Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol.Animal models of Parkinson's disease progressionHigh correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in ratsFunctional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.Stem cell grafting improves both motor and cognitive impairments in a genetic model of Parkinson's disease, the aphakia (ak) mouse.Dangguijakyak-San Protects against 1-Methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-Induced Neuronal Damage via Anti-Inflammatory Action.Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.TracMouse: A computer aided movement analysis script for the mouse inverted horizontal grid testHeptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice.Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.LLDT-67 attenuates MPTP-induced neurotoxicity in mice by up-regulating NGF expression.Functional assays for neurotoxicity testing.MPTP mouse models of Parkinson's disease: an update.
P2860
Q22252514-6805970F-80FB-4924-846E-8FDD11DD693CQ27301283-8061C0DB-A396-4D99-8E43-4ECEFCC689AFQ30380046-6E7732C5-481E-48CE-94A7-25E8C2D5D553Q30470435-CA8FC5F2-63FB-45C1-B384-4CF62E8C9160Q30474950-30DB84CA-532D-4C51-B7CA-F584CDD232F6Q30487022-758D42E5-1289-4035-8E8F-DA2A7164DB82Q30493550-F6782675-0619-467F-887B-C7B602C99662Q30512976-F9CCB503-3D49-4CFE-8B72-284B8391081FQ30519556-64861062-779F-412F-98BB-A58151E1C0C4Q33820609-F4068FF9-8A88-49E8-A49E-7511016A5DE2Q33850971-D13F2EB5-4688-482F-9F07-C286702ACA65Q33911605-61801288-17D4-4F18-B039-1E4194F5F088Q34181738-3C333DBD-8362-4F10-A8EE-0386EF5C6FE4Q34762041-E0C76FDD-D127-4B44-9E17-836F2CA1D2B8Q34769948-4526D4BE-EF03-4CF1-A67A-5F181BFC2EDBQ35675127-21429509-B44E-4BB6-91A0-AFCBA9F13835Q35887768-D6FFDA69-0F8B-4AD2-805D-6C512C0BD629Q35894167-1C580D8E-ACF3-447F-BA8F-E7AA1E26E1FAQ35922870-3F3F5789-B88E-4F3C-950D-45C23C890D26Q35925804-A240E75E-7620-49D2-B836-DB9B4A113470Q35988894-B3D3EA40-0AAA-437D-B1F8-0EDCC28B5062Q35990732-A7816DD2-E3E5-4601-91ED-37B8DCB37EE0Q36035950-6F631475-C5F4-4585-BEAA-D1F00CB3C7E6Q36200063-7F637707-6830-49E7-B763-2B748B6B4720Q36329016-B979E612-C26A-4001-8599-7653B3D2C54AQ36462680-9AB05E37-CB1A-4C96-A601-00CC886DEC7BQ36846653-68E1FE10-4E67-4ABF-9BB8-962242DA105DQ36899298-5301BB8E-32CA-4603-B69D-23E48CB5A683Q36924624-2F4F4A5B-9609-4F31-ABEA-98AAEDC838F7Q36945574-116514BC-CE98-49AC-BA3B-7F8EE8F78B33Q37034654-D0F52A71-457A-424D-91EE-1750A93C1588Q37118996-CF531AF5-2483-47E4-ACAF-648DD9C64A89Q37171891-6098258B-EED9-4520-8F66-93EE99662AE6Q37251953-21952AC3-CB90-49E0-8B57-9BA64A1FFC1FQ37508349-077D1EA3-7A4F-41B0-B8B9-1B0D19E7749DQ37621012-40287446-CDF8-4E00-ABA0-E641B03BB5F3Q37727060-06D1C76C-3D0E-459C-95C8-845F24C8A15EQ37729481-F10BC9DD-1720-4DF2-A5BE-67F8E46D1CD5Q37809406-C99F703E-0D71-4736-8FED-25DF3412CF7FQ38070400-8083C317-A038-44B3-9552-4050F99F9A84
P2860
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
@ast
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
@en
type
label
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
@ast
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
@en
prefLabel
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
@ast
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
@en
P356
P1433
P1476
Behavioral models of Parkinson's disease in rodents: a new look at an old problem.
@en
P2093
Gloria E Meredith
Un Jung Kang
P304
P356
10.1002/MDS.21010
P407
P577
2006-10-01T00:00:00Z